SILINTAN 25/pills Recalled Nationwide Due to Undeclared Meloxicam
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
ANTHONY TRINH, 123Herbals LLC has issued a voluntary recall for SILINTAN 25/pills after FDA analysis discovered the presence of undeclared meloxicam.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
ANTHONY TRINH, 123Herbals LLC is voluntarily recalling SILINTAN 25/pills after an FDA analysis revealed the presence of undeclared meloxicam. The product is also being cited for being marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The FDA has classified this as a Class I recall, indicating a high potential for serious health risks.
Which Products Are Affected
The recall involves the following product:
- Product Name: SILINTAN 25/pills
- Packaging: 25-count bottles
- Manufacturer: Shanghai Chinese Medical Works, Shanghai, China
- Code Information: All lots within expiry
- Recall Number: D-0388-2026
The product was distributed nationwide throughout the United States.
What You Should Do
Consumers who possess SILINTAN 25/pills should immediately discontinue use. While the provided data does not list specific refund instructions, consumers may contact the recalling firm, ANTHONY TRINH, 123Herbals LLC, at 7214 Berne St, Rosemead, CA 91770-3844. Healthcare professionals and consumers are encouraged to report any adverse events or quality problems experienced with the use of this product to the FDA's MedWatch Adverse Event Reporting program.
Why This Matters
This recall is significant because meloxicam is a non-steroidal anti-inflammatory drug (NSAID) that was not declared on the product label. Undeclared prescription ingredients can pose serious health risks, particularly if they interact with other medications or are consumed by individuals with specific medical conditions.
Source
FDA Recall Notice - Recall Number D-0388-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.